These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3028957)

  • 1. Role of angiotensin II in the hormonal, renal, and electrolyte response to sodium restriction.
    Rogacz S; Hollenberg NK; Williams GH
    Hypertension; 1987 Mar; 9(3):289-94. PubMed ID: 3028957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
    De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
    Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
    Hollenberg NK; Fisher ND; Price DA; Williams GH
    Am J Hypertens; 2000 May; 13(5 Pt 1):498-503. PubMed ID: 10826400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of enhanced adrenal responsiveness to angiotensin on a low salt diet.
    Rogacz S; Williams GH; Hollenberg NK
    Hypertension; 1990 Apr; 15(4):376-80. PubMed ID: 2318519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J; Wuerzner G; Jensen C; Brunner HR
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-mediated modulation of aldosterone secretion: impact of converting enzyme inhibition on rat glomerulosa cell response to angiotensin-II.
    Braley LM; Menachery A; Rystedt L; Williams GH
    Endocrinology; 1989 Sep; 125(3):1310-4. PubMed ID: 2547581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma angiotensin II concentration regulates vascular but not adrenal responsiveness to restriction of sodium intake in normal man.
    Dawson-Hughes BF; Moore TJ; Dluhy RG; Hollenberg NK; Williams GH
    Clin Sci (Lond); 1981 Nov; 61(5):527-34. PubMed ID: 7026131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
    van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
    J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological responses to angiotensin II infusion during chronic angiotensin converting enzyme inhibition in dogs on normal, low and high sodium intake.
    Olsen ME; Meydrech EF
    J Hypertens; 1985 Oct; 3(5):517-25. PubMed ID: 2999230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid modulation of renal and adrenal responsiveness to angiotensin II.
    Conlin PR; Moore TJ; Williams GH; Hollenberg NK
    Hypertension; 1993 Dec; 22(6):832-8. PubMed ID: 7503952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG; Smith K; Taylor T; Hollenberg NK; Williams GH
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
    J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
    Inglessis N; Nussberger J; Hagmann M; Hiesse-Provost O; Insuasty J; Reid J; Ménard J; Brunner HR
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):986-93. PubMed ID: 7564346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of sodium intake on physiological responses to angiotensin II in conscious dogs.
    Olsen ME; Meydrech EF
    Scand J Urol Nephrol Suppl; 1984; 79():29-34. PubMed ID: 6089315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.
    Hollenberg NK; Chenitz WR; Adams DF; Williams GH
    J Clin Invest; 1974 Jul; 54(1):34-42. PubMed ID: 4365595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.
    Schlaich MP; Klingbeil AU; Jacobi J; Delles C; Schneider MP; Schmidt BM; Schmieder RE
    J Hypertens; 2002 Jan; 20(1):117-24. PubMed ID: 11791034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man.
    McIntyre M; MacFadyen RJ; Meredith PA; Menard J; Brunner HR; Insuasty J; Reid JL
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):994-1000. PubMed ID: 7564347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.